
T2 Biosystems TTOO
Quartalsbericht 2024-Q3
hinzugefügt 14.11.2024
T2 Biosystems DPO 2011-2026 | TTOO
DPO Jährlich T2 Biosystems
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 35.9 | - | 35.3 | 81.7 | 17.6 | 19.7 | 51.1 | 258 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 258 | 17.6 | 71.3 |
DPO anderer Aktien in der Diagnostik & Forschung
| Name | DPO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Burning Rock Biotech Limited
BNR
|
125 | $ 16.24 | -2.46 % | $ 175 M | ||
|
Co-Diagnostics
CODX
|
4.24 K | $ 1.53 | - | $ 2.04 M | ||
|
Centogene N.V.
CNTG
|
120 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
50.1 | $ 111.3 | - | $ 33.8 B | ||
|
Fulgent Genetics
FLGT
|
34.9 | $ 14.8 | - | $ 447 M | ||
|
Illumina
ILMN
|
56.3 | $ 120.37 | - | $ 19.1 B | ||
|
Akumin
AKU
|
21.3 | - | -17.87 % | $ 25.9 M | ||
|
Lantheus Holdings
LNTH
|
23.6 | $ 81.17 | - | $ 5.48 B | ||
|
Biocept
BIOC
|
56.3 | - | -13.05 % | $ 7.29 M | ||
|
Medpace Holdings
MEDP
|
13.3 | $ 413.59 | - | $ 11.9 B | ||
|
Aspira Women's Health
AWH
|
189 | - | -6.19 % | $ 10.5 M | ||
|
Accelerate Diagnostics
AXDX
|
125 | - | -61.36 % | $ 2.46 M | ||
|
NeoGenomics
NEO
|
19.7 | $ 8.96 | - | $ 1.15 B | ||
|
National Research Corporation
NRC
|
10.1 | $ 16.54 | - | $ 370 M | ||
|
Personalis
PSNL
|
67.3 | $ 5.04 | - | $ 299 M | ||
|
CareDx, Inc
CDNA
|
44.2 | $ 20.8 | - | $ 1.11 B | ||
|
Senseonics Holdings
SENS
|
68 | $ 6.43 | - | $ 268 M | ||
|
Chembio Diagnostics
CEMI
|
52.5 | - | 0.22 % | $ 16.8 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
45.8 | - | - | $ 562 M | ||
|
Castle Biosciences
CSTL
|
52 | $ 24.24 | - | $ 673 M | ||
|
Thermo Fisher Scientific
TMO
|
49.3 | $ 466.26 | - | $ 176 B | ||
|
Trinity Biotech plc
TRIB
|
163 | $ 0.6 | - | $ 61.9 M | ||
|
Twist Bioscience Corporation
TWST
|
12.5 | $ 56.7 | - | $ 3.39 B | ||
|
DermTech
DMTK
|
47.4 | - | -11.32 % | $ 2.94 M | ||
|
Global Cord Blood Corporation
CO
|
17.7 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
61.4 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
780 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
43.5 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
24.5 | $ 163.84 | - | $ 8.12 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
8.98 | - | - | $ 10.7 B | ||
|
Enzo Biochem
ENZ
|
52.3 | - | -8.98 % | $ 14.8 K | ||
|
Exact Sciences Corporation
EXAS
|
49.2 | - | - | $ 19.8 B | ||
|
Guardant Health
GH
|
48.6 | $ 83.41 | - | $ 10.5 B | ||
|
Heska Corporation
HSKA
|
39.7 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
112 | - | -20.0 % | $ 1.06 M | ||
|
Interpace Biosciences
IDXG
|
33 | $ 1.99 | 2.9 % | $ 8.8 M | ||
|
QIAGEN N.V.
QGEN
|
50 | - | - | $ 10.6 B | ||
|
Biomerica
BMRA
|
32.4 | $ 2.16 | - | $ 4.96 M | ||
|
ICON Public Limited Company
ICLR
|
6.52 | $ 116.17 | - | $ 9.58 B | ||
|
Laboratory Corporation of America Holdings
LH
|
31.5 | $ 257.14 | - | $ 21.4 B | ||
|
Motus GI Holdings
MOTS
|
1.72 | - | -34.28 % | $ 263 K | ||
|
Neogen Corporation
NEOG
|
62.7 | $ 9.01 | - | $ 1.95 B | ||
|
Invitae Corporation
NVTA
|
69 | - | - | $ 21.2 M | ||
|
Myriad Genetics
MYGN
|
45.9 | $ 4.68 | - | $ 433 M | ||
|
OpGen
OPGN
|
95 | - | -16.95 % | $ 1.54 M | ||
|
Natera
NTRA
|
17.9 | $ 194.75 | - | $ 19.2 B | ||
|
Quest Diagnostics Incorporated
DGX
|
14.7 | $ 189.32 | -0.03 % | $ 21 B |